
An expert panel discussion for clinicians on the most important factors surrounding a safe return-to-school plan, including testing, masking, social distancing, vaccine prioritization and more.

An expert panel discussion for clinicians on the most important factors surrounding a safe return-to-school plan, including testing, masking, social distancing, vaccine prioritization and more.

Unique model demonstrates how clinical pharmacy services could be integrated into an interprofessional telehealth clinic.

Researchers attempt to address a lack of evidence showing that schools have a role in the transmission of COVID-19.

Top news of the week from Pharmacy Times®.

What constipation remedy did Lewis and Clark take on their famed expedition?

Venlafaxine Hydrochloride ER capsules is used to treat major depressive disorder, anxiety and panic disorder.

Leaders of Operation Warp Speed optimistic for a coronavirus disease 2019 vaccine following multi-billion dollar investments in several candidates.

NACDS states that although prescription drug discount cards were put in place to reduce out-of-pocket costs, states have been using the data in a manner inconsistent with federal law and policy.

Stephanie Young Moss, PharmD, MS, discussed how to begin finding your niche as a pharmacist on social media.

Vitolarsen is the second FDA-approved targeted treatment for patients with Duchenne muscular dystrophy who have a confirmed mutation of the gene that is amenable to exon 53 skipping.

Analysis suggests that the current diabetes screening criteria, despite covering about a quarter of US children and adolescents, do not capture many youth with hyperglycemia.

Like so many other conferences and events, ASCO transitioned to an online format because of the coronavirus disease 2019 (COVID-19) outbreak.

The 2020 NCPA Annual Convention will be held exclusively online October 18-19, 2020.

Study shows significant genomic differences between tumors caused by different strains of human papillomavirus.

The peptide, also known as Pept-ins, already proved to be a valuable approach to tackle bacterial pathogens or slow down tumor growth, according to the study authors.

Symptoms of polycystic ovary syndrome, such as obesity and diabetes, can lead to a 19% higher risk of heart disease.

BAM15 may help reduce the amount of food a person eats or the calories their bodies absorb.

Ozanimod (Zeposia) became the third oral S1P modulator approved by the FDA for the treatment of multiple sclerosis,

Uncertainties persist regarding the transmission of COVID-19 among students in educational settings as schools prepare to reopen in some form.

The combination of sintilimab, pemetrexed, and a platinum-based chemotherapy has shown promise for nonsquamous non-small cell lung cancer.

Improving hospital prescribing practices may reduce the risk of rehospitalization and death in older adults.

Human papillomavirus vaccine may reduce the chance of high-grade cervical intraepithelial neoplasis.

The death rate for patients who experienced a normally lower-risk heart attack rose sharply during the peak of the coronavirus disease 2019 pandemic.

Pharmacy managers must maintain close control over operations, and this case makes a strong argument for taking care in selecting the right personnel.

Frontline health care workers have a 3-fold increased risk of contracting coronavirus disease 2019 despite use of personal protective equipment.

A new blood test for Alzheimer disease could provide a more sensitive, accurate indicator of plaques and tangles corresponding to the disease in living people.

Moderna will manufacture doses of its experimental coronavirus disease 2019 vaccine candidate as clinical trials are ongoing to expedite the production process.

Intranasal vaccine platform may allow for an immune response to be induced more precisely to provide the best possible protection from coronavirus disease 2019.

Test combines multiple factors that influence whether a child is likely to develop type 1 diabetes.

New online training program is being deployed in response to data indicating a surge in opioid-related overdoses during the COVID-19 pandemic.